Atrial Fibrillation Market Opportunities by 2027 - AtriCure, Biosense Webster, Boehringer Ingelheim, Boston Scientific, Bristol- Myers Squibb, Cardio Focus, Endoscopic Technologies, Sanofi, and Abbott
The global atrial fibrillation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading atrial fibrillation market players and offers key trends and opportunities in the market.
Download PDF sample copy of this Study: https://www.theinsightpartners.com/sample/TIPRE00003531/
The atrial fibrillation market is anticipated to grow in the forecast period owing to driving factors such as rise in the prevalence of obesity and hypertension in elderly population, reduced mortality rate and favorable outcomes of the atrial fibrillation devices. However, the catheter related complications and high cost of minimally invasive ablation procedures eventually hinders the market growth.
Atrial fibrillation is arrhythmias that refers to an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Technical development in the field of surgical catheter ablation along with rising occurrence of disease due to changes lifestyle habits like drinking and smoking will drive the growth of global atrial fibrillation device market in forecast period.
1. AtriCure Inc.
2. Biosense Webster Inc.
3. Boehringer Ingelheim GmbH
4. Boston Scientific Corporation
5. Bristol- Myers Squibb Corporation
6. Cardio Focus Inc.
7. Endoscopic Technologies Inc.
10. Johnsons & Johnson Services, Ltd.
The global atrial fibrillation market is segmented on the basis of treatment type and end user. Based on treatment type, the market is segmented as non-pharmacological and pharmacological. The atrial fibrillation market, based on end user is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories.
Buy the complete report with Comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPRE00003531/
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global atrial fibrillation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The atrial fibrillation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atrial Fibrillation Market Opportunities by 2027 - AtriCure, Biosense Webster, Boehringer Ingelheim, Boston Scientific, Bristol- Myers Squibb, Cardio Focus, Endoscopic Technologies, Sanofi, and Abbott here
News-ID: 1838045 • Views: 532
More Releases from The Insight Partners
Sales Enablement Platform Market 2020 – New Business Strategies, Technological …
The latest report on ‘Sales Enablement Platform Market’ now available at The Insight Partners, delivers facts and numbers regarding the market size, geographical landscape and profit forecast of the ‘Sales Enablement Platform Market’. In addition, the report focuses on major obstacles and the latest growth plans adopted by leading companies in this business. The sales enablement platform market is increasingly gaining traction with the global rise in the startup ecosystem coupled
Digital Experience Platform Market 2020 – New Business Strategies, Technologic …
The latest report on ‘Digital Experience Platform Market’ now available at The Insight Partners, delivers facts and numbers regarding the market size, geographical landscape and profit forecast of the ‘Digital Experience Platform Market’. In addition, the report focuses on major obstacles and the latest growth plans adopted by leading companies in this business. As this platform assist the enterprises to match up with changing customer needs, DXP is gaining high momentum
Digital Banking Platform Market 2020 – New Business Strategies, Technological …
The increasing digital transformation revolution in banking industry presents a massive opportunity for digital banking platform providers as they enable banks to launch digital services faster and enhance the customer experience. In addition to this, the proliferation of smart devices, easy availability of internet, the advancement of IoT, and in Artificial Intelligence have been increasing exponentially, which is further leading to the increasing need of mobile/digital-first strategy among banks. The
Smart Display Market 2020 Top Countries Industry Growth, Size, Share, Competitiv …
The proposed Smart Display Market 2020 report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Smart Display Market sample report includes an exclusive
More Releases for Atrial
Atrial Fibrillation Device Market Latest Trends and Forecast Analysis - 2026
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Fibrillation - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atrial Fibrillation - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body.